ESR1 and breast cancer: Therefore, our purpose was to determine whether molecular subtype, as defined by estrogen receptor (ER), progesterone receptor (PR), Ki-67, and HER-2, correlates with presenting features of breast cancer, particularly to evaluate whether it is an independent predictor of axillary lymph node involvement on multivariable analysis.